Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Maik Schwarz"'
Autor:
Alice Diepers, Susann Schulze, Nadja Jäkel, Danny Misiak, Christina Zahn, Claudia Spohn, Regina Moeller, Dietrich Kämpfe, Maik Schwarz, Katrin Nerger, Bayram Edemir, Haifa Kathrin Al-Ali
Publikováno v:
HemaSphere, Vol 7, p e602412a (2023)
Externí odkaz:
https://doaj.org/article/182347e72ff94e7595d7ac32573a3965
Autor:
Sabrina Jotschke, Susann Schulze, Nadja Jaekel, Beatrice Ludwig-Kraus, Robby Engelmann, Frank Bernhard Kraus, Christina Zahn, Nicole Nedlitz, Gabriele Prange-Krex, Johannes Mohm, Bettina Peuser, Maik Schwarz, Claudia Spohn, Timo Behlendorf, Mascha Binder, Christian Junghanss, Sebastian Böttcher, Haifa Kathrin Al-Ali
Publikováno v:
Cancers, Vol 14, Iss 6, p 1544 (2022)
Purpose: To assess humoral responses longitudinally and cellular immunogenicity following SARS-CoV-2-vaccination in patients with hematologic and oncologic malignancies receiving checkpoint-inhibitors. Methods: This prospective multicenter trial of t
Externí odkaz:
https://doaj.org/article/260125fd83ab40e0a22cb380b2234abd
Autor:
Cornelia Becker, Wolfram Pönisch, Maik Schwarz, Markus Scholz, Madlen Jentzsch, Uwe Platzbecker, Andreas Schwarzer, Bruno Holzvogt, Georg-Nikolaus Franke, Uta Schönfelder-Fricke, Juliane Grimm, Leanthe Braunert, Yvonne Remane, Marc Andrea, Thomas Zehrfeld, Sebastian Schwind, Thomas Edelmann, Franz Albert Hoffmann, Tanja Holzhey, Song-Yau Wang, Doreen Hammerschmidt, Markus Bill, Madlen Holzvogt
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Introduction Light chain involvement is observed in almost every patient (pt) with newly diagnosed multiple myeloma (MM). Owing to a relatively short half-life, rapid reduction in the involved free light chain (iFLC) is of potential prognostic value.
Autor:
Hans-Juergen Hurtz, Joern Ruessel, Christian Junghanss, Thoralf Lange, Nadja Jaekel, Dietrich Kaempfe, Claudia Spohn, Peter Tornow, Regina Moeller, Brigitte Kragl, Susann Schulze, Ute Neef, Maik Schwarz, Tony Hennersdorf, Kathleen Jentsch-Ullrich, Haifa Kathrin Al-Ali, Marion Schmalfeld
Publikováno v:
Blood. 136:13-13
Thrombosis is the major cause of morbidity and mortality in polycythemia vera (PV) and essential thrombocythemia (ET). Age ≥60 years (y) and/or history of thrombosis labels patients (pts) as high-risk for thrombosis. Yet, thrombosis frequently occu
Publikováno v:
European Journal of Operational Research. 243:454-464
Two methods for ranking of solutions of multi objective optimization problems are proposed in this paper. The methods can be used, e.g. by metaheuristics to select good solutions from a set of non dominated solutions. They are suitable for population
Autor:
Dietger Niederwieser, Ute Kreibich, Christoph Kahl, Dietrich Kämpfe, Stephan Wilhelm, Norbert Grobe, Georg Maschmeyer, Maik Schwarz, Michael Aßmann, Lars-Olof Mügge, Susanne Köhler
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 141:1639-1644
There is a paucity of data on the incidence of neuroendocrine tumors (NET) outside pulmonary primaries and on treatment modalities applied to patients with NET in clinical practice. Only very little therapeutic progress has been made with respect to
Autor:
Marius Bill, Cornelia Becker, Rainer Krahl, Hannah Tessenow, Christian Pfrepper, Georg Franke, Sebastian Schwind, Vladan Vucinic, Madlen Jentzsch, Thomas Zehrfeld, Madlen Holzvogt, Dietger Niederwieser, Sabine Leiblein, Marc Andrea, Simone Heyn, Thoralf Lange, Bruno Holzvogt, Thomas Schliwa, Maik Schwarz, Wolfram Pönisch
Publikováno v:
Journal of cancer research and clinical oncology. 143(10)
Patients with light chain myeloma frequently have a light chain tubular cast nephropathy, which can lead to severe renal impairment. In the present retrospective study, bortezomib was combined with other active substances like bendamustine and predni
Autor:
Simone Heyn, Evelin Hennig, Rainer Krahl, Dietger Niederwieser, Thomas Edelmann, Thomas Schliwa, Yvonne Remane, Kolja Reifenrath, Cornelia Becker, Thomas Zehrfeld, Tom H. Lindner, Marc Andrea, Gerhard Behre, Ute Kreibich, Maik Schwarz, Andreas Schwarzer, Vladan Vucinic, Madlen Plötze, Bruno Holzvogt, Kerstin Gutsche, Cornelia Winkelmann, Malvina Bourgeois, Franz Albert Hoffmann, Thorsten Kaiser, Doreen Hammerschmidt, Wolfram Pönisch
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 140:1947-1956
Bortezomib is a proteasome inhibitor that has shown important clinical efficacy either as a single agent or in combination in patients with multiple myeloma (MM). In the present protocol, bortezomib was combined with bendamustine and prednisone, in o
Autor:
Jan Johannes, Maik Schwarz
Publikováno v:
Communications in Statistics - Theory and Methods. 42:1343-1362
This work deals with the ill-posed inverse problem of reconstructing a function $f$ given implicitly as the solution of $g = Af$, where $A$ is a compact linear operator with unknown singular values and known eigenfunctions. We observe the function $g
Autor:
Thomas Zehrfeld, Ina Wagner, Ute Kreibich, Sirak Petros, Marc Andrea, Doreen Hammerschmidt, Tom H. Lindner, Andreas Schwarzer, Maik Schwarz, Anette Bachmann, Cornelia Winkelmann, Wolfram Pönisch, Dietger Niederwieser
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 138:1405-1412
Renal failure is a frequent complication of multiple myeloma (MM) and, if present at diagnosis, a considerable risk factor for outcome. Treatment with chemotherapy and/or new agents may result in recovery of renal function in up to 50 % of patients.